ベータ
治験レーダーAI
治験 NCT06744491 (NFRF)(対象:身体的不活動、老化、健康な老化、Growth & Development、性差、Anabolic Sensitivity、Protein Metabolism、身体活動)は募集未定です。詳細は治験レーダーのタイル表示と AI 発見ツールで確認するか、ここで質問してください。
フィルター基準に一致する試験が1件見つかりました
タイル表示

Oral 'Breath Test' to Measure Anabolic Sensitivity to a Protein Meal Across the Age and Physical Activity Spectrum (NFRF)

募集未定
治験(臨床試験)の詳細は主に英語で提供されています。しかし、治験レーダーAIが支援できます!「治験を説明」をクリックして、選択した言語で試験情報を表示し、議論してください。
治験番号 NCT06744491 (NFRF) は 観察研究 臨床試験 で、身体的不活動、老化、健康な老化、Growth & Development、性差、Anabolic Sensitivity、Protein Metabolism、身体活動 に関するものです。現在は 募集未定 で、2024年12月20日 に開始予定です。80 名の参加者 の募集が計画されています。この治験は トロント大学 によって主催され、2025年8月31日 に完了予定です。ClinicalTrials.gov からの最新更新日は 2024年12月20日 です。
概要
The purpose of this study is to determine how anabolic sensitivity, in response to the ingestion of a liquid protein meal, differs across the lifespan, between biological sexes, and with varying physical activity levels.
詳細説明
Skeletal muscle is a dynamic tissue that responds to anabolic (i.e., growth) stimuli such as protein ingestion and exercise. Differences in age and physical activity levels will influence an individual's ability to respond to these anabolic stimuli; this concept is known as anabolic sensitivity. For instance, older and less physically active individuals will display lower anabolic sensitivity (i.e., anabolic resistance) to a bout of exercise or the consumption of protein in comparison to younger, more physically active individuals. Seeing that individuals with anabolic resistance are at a greater risk for losing muscle mass over time, it is important to understand the anabolic sensitivity/resistance of an individual to assess for the efficiency of growth across the health and lifespan, in addition to a potential screen for metabolic alterations that could manifest into changes in lean body and muscle mass.

Traditional methods to assess for skeletal muscle anabolism and protein metabolism requires in-person and invasive research methods (i.e., stable isotope infusions and muscle biopsies) in controlled laboratory or clinical settings. However, there are many risks associated with these invasive procedures and they are not always feasible in all populations (e.g., children, clinical populations, etc..). Our lab has recently developed a non-invasive 13C breath test which employs an oral stable isotope tracer. Our breath test allows us to assess for anabolic sensitivity in response to protein ingestion, by determining how much of the ingested protein was used to build (synthesize) new proteins in our body (i.e., anabolism) or used as a source of energy (through a process called oxidation). As such, the purpose of the present study is to determine how anabolic sensitivity, in response to the ingestion of a liquid protein meal, differs across the lifespan and with varying physical activity levels.

公式タイトル

Anabolic Sensitivity Across the Lifespan

疾患/病気
身体的不活動老化健康な老化Growth & Development性差Anabolic SensitivityProtein Metabolism身体活動
その他の研究識別子
  • NFRF
  • 00044004
NCT番号
開始日
2024-12-20
最終更新日
2024-12-20
終了予定日
2025-08-31
目標参加者数
80
試験の種類
観察研究
状況
募集未定
キーワード
anabolic sensitivity
aging
growth and development
physical activity
skeletal muscle
stable isotopes
群(アーム)/介入
参加グループ/群介入/治療法
Children
Children as defined by maturity offset via age from peak height velocity (aPHV \< -1.0 years).
該当なし
Adolescent
Adolescents as defined by maturity offset via age from peak height velocity (aPHV -0.5 to +1.5 years)
該当なし
Young Adults
Young adults as defined by chronological age between ages 18 - 35 years
該当なし
Older Adults
Older adults as defined by chronological age between ages 60 - 80 years
該当なし
主要評価項目
評価指標指標の説明時間枠
Amino acid oxidation and net protein balance
Amino acid oxidation and net protein balance assessed by oral 1-13C Leucine tracer. Net protein balance is derived from the difference between amino acid intake (known) and total amino acid oxidation over the 6h post-prandial measurement period.
6 Hours
適格基準

対象年齢
小児, 成人, 高齢者
試験の最低年齢
8 Years
対象性別
全て
健康なボランティアを受け入れる
はい
  • Healthy will be defined as screened by the PAR-Q+ (The Physical Activity Readiness Questionnaire for everyone)
  • Chronological age for Healthy Young (age: 18-35 years) or Older (age: 60-80 years) adults
  • Chronological age between 8 to 16 years, with maturity offset < -1 year from age of Peak Height Velocity (aPHV) for children and between -0.5 to +1.5 years from aPHV in adolescent participants
  • BMI between normal to overweight (18.5 - 29.9 kg/m2)

  • Regular use of nonsteroidal anti-inflammatory dugs (with the exception of daily low-dose aspirin)
  • use of anticoagulants
  • use of a walker, cane, or assistive walking device
  • infectious or gastrointestinal disease
  • inability to comply with study protocol (e.g., unable to track diet)
  • regular tobacco use
  • self-reported illicit drug use (e.g., growth hormone, testosterone, etc.)
  • diagnosed chronic illness (e.g., type 2 diabetes, heart disease, thyroid disease)
  • pregnant
  • hormonal replacement therapy
責任者
Daniel Moore, 研究責任者, Professor, Muscle Physiology, University of Toronto
試験中央連絡先
連絡先: Daniel R Moore, PhD, 4169464088, [email protected]
連絡先: Hugo JW Fung, PhD Candidate, [email protected]
1 1カ国の場所

Ontario

Goldring Center for High Performance Sport, Toronto, Ontario, M5S 2C9, Canada
Hugo JW Fung, PhD Candidate, 連絡先, 416-946-5620, [email protected]